The FMP conducts basic research in Molecular Pharmacology with the aim to identify novel bioactive molecules and to characterize their interactions with their biological targets in cells or organisms. These compounds are useful tools in basic biomedical research and may be further developed for the treatment, prevention, or diagnosis of disease.
To this aim FMP researchers study key biological processes and corresponding diseases, such as cancer, aging including osteoporosis, or neurodegeneration. They also develop and apply advanced technologies ranging from screening technologies over NMR based methods to proteomics and in vivo models.

Life Sciences

Research

Therapeutics

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

Prof. Dr. Dorothea Fiedler

Al - Yamori

Von Kries

Van Rossum

Nazaré Group

Jan Vincent

Ida Marie

Caspar Jonas

Borges Lima

Ida Marie Vedel

Gillian Dornan

Dr. Christopher Schmied

Wen - Ting

Von Oertzen

Mcmillan Centeno

Kristin Kemnitz

Kemnitz - Hassanin

Jens Peter

Fiedler Group

De Geus

Al Beiruty

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

Org chart

Similar companies